e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
New insights into the treatment of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reliability of death certificates regarding COPD mortality in the TORCH study
L. McGarvey, M. Zvarich, J. Anderson, N. Thomas, M. John, R. Wise (Belfast, Greenford, United Kingdom; RTP, NC, Baltimore, MD, United States Of America; Prerow, Germany)
Source:
Annual Congress 2007 - New insights into the treatment of COPD
Session:
New insights into the treatment of COPD
Session type:
Thematic Poster Session
Number:
3584
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. McGarvey, M. Zvarich, J. Anderson, N. Thomas, M. John, R. Wise (Belfast, Greenford, United Kingdom; RTP, NC, Baltimore, MD, United States Of America; Prerow, Germany). Reliability of death certificates regarding COPD mortality in the TORCH study. Eur Respir J 2007; 30: Suppl. 51, 3584
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Clinical examination and all-cause mortality in non-mild COPD population – prospective study
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Mortality by cause of death and spirometric pattern in a population-based study
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019
Trends in COPD mortality – Tales from the Swedish mortality register
Source: Eur Respir J 2003; 22: Suppl. 45, 485s
Year: 2003
10-year follow-up of hospitalised COPD-patients: Comorbidities, mortality and cause of death
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Mortality figures for chronic obstructive pulmonary disease obtained from death certificates underestimate the true burden of disease; a five year retrospective analysis
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
Risk charts of five-year mortality in COPD patients
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019
Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data
Source: ERJ Open Res, 5 (4) 00125-2019; 10.1183/23120541.00125-2019
Year: 2019
Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit
Source: Eur Respir J 2016; 47: 113-121
Year: 2016
Association between biomarkers at discharge and risk of readmission after community-acquired pneumonia – a retrospective cohort study
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Predicting 12-month mortality in a Scottish COPD cohort
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Predictors of mortality in COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Predictors of mortality in COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008
Age cohort mortality differences for respiratory and cardiovascular causes of death
Source: Eur Respir J 2001; 18: Suppl. 33, 151s
Year: 2001
Reliability of cause-specific mortality adjudication in the TORCH clinical trial
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
Factors associated with mortality in the TORCH trial in COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 356s
Year: 2007
Comorbidity, hospitalization and mortality in COPD: Results from a longitudinal study
Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept